KineMed Revenue and Competitors
Estimated Revenue & Valuation
- KineMed's estimated annual revenue is currently $3.1M per year.
- KineMed's estimated revenue per employee is $155,000
Employee Data
- KineMed has 20 Employees.
- KineMed grew their employee count by -5% last year.
KineMed's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, Chairman Scientific Advisory Board | Reveal Email/Phone |
2 | CEO & Chairman | Reveal Email/Phone |
KineMed Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is KineMed?
KineMed, Inc. (www.kinemed.com), a privately held biotechnology company based in Emeryville, CA, is a leader in translational and personalized medicine. KineMed uses the administration of stable (non-radioactive) isotopes to provide high-definition pharmacological measurements of disease activity and drug effects across a wide range of therapy areas, including diseases of the nervous system, metabolic and cardiovascular diseases, cancer, inflammation, and musculoskeletal diseases. KineMed is developing a focused, high-quality pipeline of its own in-licensed compounds.
keywords:N/A
N/A
Total Funding
20
Number of Employees
$3.1M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Emeryville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.7M | 20 | 0% | N/A |
#2 | $2M | 20 | 5% | N/A |
#3 | $2M | 20 | -20% | N/A |
#4 | $2.1M | 21 | 5% | N/A |
#5 | $4.2M | 21 | 24% | N/A |